Today, the CCO of Pacific Biosciences (PACB), Kathy Ordonez, sold shares of PACB for $188.5K.
See today’s analyst top recommended stocks >>
Currently, Pacific Biosciences has an average volume of 1.78M. The Company has a Price to Book ratio of 8.5466.
Based on 3 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $7.50, reflecting a -0.5% downside.
In the last 30 days, insiders have sold $188.5K worth of PACB shares and purchased $72.5K worth of PACB shares.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Pacific Biosciences of California, Inc. engages in the research, development, and manufacture of sequencing systems for genetic analysis. It operates through the following geographical segments: North America, Europe, and Asia Pacific (including the Middle East).
